Azeria Therapeutics

Developer of therapies for treating hormone-resistant breast and prostate cancer

placeCambridge, England, United Kingdom calendar_todayFounded 2017 groups11 employees language azeriatherapeutics.com

Registered entities

Investor mix

2 investors on record; lead investors include Syncona, Sixth Element Capital.

Investor typeCountShare
Venture capital2100%
Coming soon